Skip to main content
Have a personal or library account? Click to login
The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis Cover

The importance of the new prognostic scoring system for evaluating patients with lower-risk myelodysplastic syndrome at diagnosis

Revista Romana de Medicina de Laborator
Volume 21 (2013): Issue 3 (September 2013)
By: ,  ,  ,  ,  ,  ,  ,  ,  ,  ,  ,   and    
Open Access
|Sep 2013
References

References

  1. 1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 1982, 51:189-199.
    Open DOISearch in Google Scholar
  2. 2. Cazzola M, Malcovati L: Myelodysplastic syndromes -coping with ineffective hematopoiesis. N Engl J Med, 2005, 352: 536-538.
    Open DOISearch in Google Scholar
  3. 3. Vardiman JW, Harris NL, Brunning RD: The new World Health Organization classification of myeloid neoplasms: Blood, 2002, 100:2292-2302.
    Open DOISearch in Google Scholar
  4. 4. Fenaux P: Myelodysplastic syndromes: from pathogenesis and prognosis to treatment. SeminHematol., 2004;41:6-12.
    Open DOISearch in Google Scholar
  5. 5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G: International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes. Blood, 1997; 89:2079-2088.
    Open DOISearch in Google Scholar
  6. 6. Greenberg P, Tuechler H, Schanz J, Sanz G, Solé F, Bennett J et al: Revised International Prognostic Scoring System for Myelodysplastic Syndromes. Blood, 2012 120: 2454-2465.
    Open DOISearch in Google Scholar
  7. 7. Swansbury J: Methods in Molecular Biology TMCancer Cytogenetics Methods and Protocols.Humana, 2003;220: 43-56.
    Search in Google Scholar
  8. 8. Shaffer LG, Slovak ML, Campbell JL: An International System for Human Cytogenetic Nomenclature, 2009.
    Search in Google Scholar
  9. 9. Nowell PC. Chromosome abnormalities in myelodysplastic syndromes. SeminOncol, 1992;19:1925-1929.
    Search in Google Scholar
  10. 10. Haase D, Germing U, Schanz J, Pfeilstöcker M, Nösslinger T, Steidl N: New insights into the prognostic impact of the karyotype in MDS andcorrelation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007, 110: 4385-4395
    Open DOISearch in Google Scholar
  11. 11. De Witte T, Hermans J, Vossen J, Bacigalupo A., Meloni G., Jacobsen N. et al:Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).Br J Haematol,2000;110:620-630.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/rrlm-2013-0033 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Journal RSS Feed
Language: English, Romanian
Page range: 343 - 351
Published on: Sep 19, 2013
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Keywords:
myelodisplastic syndromes,
International Prognostic Scoring System (IPSS),
Revised International Prognostic Scoring System (R-IPSS)
Related subjects:
Life sciences,
Molecular biology

© 2013 Aurelia Tatic, Cerasela Jardan, Otilia Georgescu, Oana Stanca, Madalina Vasilica, Sorina Badelita, Ana Manuela Crisan, Adriana Colita, Dan Colita, Genica Vulcan, Anca Roxana Lupu, Ionel Iosif, Daniel Coriu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.

Volume 21 (2013): Issue 3 (September 2013)
Previous article
Next article